• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    8/28/23 1:52:48 PM ET
    $AEHR
    $AGIL
    $AIXI
    $APM
    Electrical Products
    Industrials
    Professional Services
    Consumer Discretionary
    Get the next $AEHR alert in real time by email

    Gainers

    • Mobile Infrastructure Corporation (NASDAQ:BEEP) shares jumped 98.7% to $12.02.
    • GD Culture Group Limited (NASDAQ:GDC) gained 61.8% to $4.11 after it announced the launch of live-streaming e-commerce business on TikTok, a popular social media platform.
    • Hersha Hospitality Trust (NYSE:HT) shares climbed 56.5% to $9.82 after it announced a merger with KSL Capital Partners LLC, an investor in travel and leisure businesses.
    • Bionomics Limited (NASDAQ:BNOX) rose 54% to $2.3550.
    • Hawaiian Electric Industries, Inc. (NYSE:HE) gained 41.8% to $13.70 after the company released an in-depth response to the lawsuit recently filed by the County of Maui surrounding the tragic fires on August 8.
    • Genius Group Limited (NYSE:GNS) shares climbed 35.6% to $1.98 after jumping 29% on Friday.
    • Thorne HealthTech, Inc. (NASDAQ:THRN) gained 29.3% to $10.10 after the company entered an agreement to be acquired by L Catterton for $10.20 per share in cash.
    • Micromobility.com Inc. (NASDAQ:MCOM) shares climbed 28.5% to $0.1028 after gaining 20% on Friday.
    • LQR House Inc. (NASDAQ:LQR) shares climbed 27.5% to $1.30. The company's board authorized a share repurchase program, along with an innovative marketing partnership with Gold Standard Media.
    • IM Cannabis Corp. (NASDAQ:IMCC) rose 22.4% to $0.8450.
    • Selina Hospitality PLC (NASDAQ:SLNA) gained 22.2% to $0.6601. Globant S.A. recently inked a global corporate brand partnership with Selina Hospitality.
    • RPT Realty (NYSE:RPT) rose 20% to $11.48. Kimco Realty penned a merger agreement to acquire RPT Realty in an all-stock transaction for around $2 billion, including the assumption of debt and preferred stock.
    • VinFast Auto Ltd. (NASDAQ:VFS) shares climbed 17.2% to $80.60 after jumping 40% on Friday.
    • Rite Aid Corporation (NYSE:RAD) jumped 15.7% to $0.8155. Rite Aid is reportedly on the brink of filing for bankruptcy amidst many lawsuits over its purported role in the opioid crisis to address its significant debt burden, which exceeds $3.3 billion, through a Chapter 11 filing.
    • Sangamo Therapeutics, Inc. (NASDAQ:SGMO) gained 15.5% to $0.8900.
    • NeuroMetrix, Inc. (NASDAQ:NURO) gained 13.5% to $0.75.
    • BrightView Holdings, Inc. (NYSE:BV) gained 12.2% to $9.15 after the company announced it received a $500 million strategic investment in convertible preferred stock from an affiliate of One Rock Capital Partners.
    • Vahanna Tech Edge Acquisition I Corp. (NASDAQ:VHNA) rose 11% to $10.71. On Aug. 28, 2023, Vahanna Tech Edge Acquisition I Corp. issued a press release, announcing that its previously announced business combination with Roadzen, Inc., was approved at a special meeting of Vahanna shareholders on Aug. 25, 2023.
    • Novavax, Inc. (NASDAQ:NVAX) climbed 9.2% to $8.78.
    • Aehr Test Systems (NASDAQ:AEHR) gained 9.2% to $45.33.
    • FLJ Group Limited (NASDAQ:FLJ) shares rose 8.7% to $0.2001. FLJ Group is scheduled to hold its 2023 annual general meeting on Sept. 18, 2023.
    • BioNexus Gene Lab Corp. (NASDAQ:BGLC) shares surged 8% to $1.4037 after jumping 10% on Friday.
    • Jabil Inc. (NYSE:JBL) gained 7.5% to $111.05 after it reached a preliminary deal for potential $2.2B sale of Mobility business To BYD Electronic.

    Losers

    • AgileThought, Inc. (NASDAQ:AGIL) shares fell 32.6% to $0.1753. Alliance Global Partners downgraded AgileThought from Buy to Sell.
    • NovoCure Limited (NASDAQ:NVCR) fell 31.4% to $20.42 after the company announced its Phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 trial of TTFields with paclitaxel did not meet its primary endpoint.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) fell 23.9% to $9.47. Faraday Future announced a 1-for-80 reverse stock split and authorized share reduction from 1,765,000,000 to 154,437,500.
    • Heliogen, Inc. (NYSE:HLGN) shares fell 18.7% to $0.2002 after the company reported a 1-for-35 reverse stock split.
    • Xiao-I Corporation (NASDAQ:AIXI) declined 16.6% to $3.32.
    • Ideanomics, Inc. (NASDAQ:IDEX) fell 15.5% to $3.6341 after the company reported results for the second quarter.
    • Opthea Limited (NASDAQ:OPT) fell 15.3% to $2.61. Opthea successfully completed institutional offer and increased capital raising to A$90.0 million.
    • Mullen Automotive, Inc. (NASDAQ:MULN) dipped 12.9% to $0.5651. Mullen announced a Class 3 vehicle purchase order with NRTC Automation Group.
    • ReTo Eco-Solutions, Inc. (NASDAQ:RETO) fell 12.3% to $0.9550 after declining 4% on Friday.
    • BTC Digital Ltd. (NASDAQ:METX) declined 11.7% to $2.04.
    • Scilex Holding Company (NASDAQ:SCLX) fell 10.9% to $2.93.
    • Electriq Power Holdings, Inc. (NYSE:ELIQ) fell 9.3% to $2.1402 after declining 21% on Friday.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) declined 8.9% to $6.44.
    • Aptorum Group Limited (NASDAQ:APM) shares fell 8% to $2.0250 after jumping 27% on Friday.
    • Nikola Corporation (NASDAQ:NKLA) tumbled 7.3% to $1.21. The company last week announced its intention to conduct a registered direct offering involving senior convertible notes, the total value of which could reach up to $325 million. Anticipated net proceeds for Nikola stand at approximately $124.5 million.
    • YS Biopharma Co., Ltd. (NASDAQ:YS) fell 7.2% to $1.16. YS Biopharma shares jumped over 65% on Friday after the company announced the purchase of shares by company officers.
    • Upwork Inc. (NASDAQ:UPWK) fell 5.4% to $13.96 after BTIG downgraded the stock from Buy to Neutral.

     

    Now Read This: This Analyst With 86% Accuracy Rate Sees Around 37% Upside In Nvidia - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

    Get the next $AEHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEHR
    $AGIL
    $AIXI
    $APM

    CompanyDatePrice TargetRatingAnalyst
    Aehr Test Systems
    $AEHR
    3/2/2026Mkt Perform → Outperform
    William Blair
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Hawaiian Electric Industries Inc.
    $HE
    1/20/2026$12.50Hold → Underperform
    Jefferies
    Rithm Property Trust Inc.
    $RPT
    1/7/2026$24.00Buy
    Compass Point
    Rithm Property Trust Inc.
    $RPT
    12/30/2025$4.00Outperform
    Wedbush
    Aehr Test Systems
    $AEHR
    12/17/2025$29.00Buy
    Lake Street
    BrightView Holdings Inc.
    $BV
    12/2/2025$15.00Buy
    BTIG Research
    Sangamo Therapeutics Inc.
    $SGMO
    11/7/2025$1.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $AEHR
    $AGIL
    $AIXI
    $APM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Scott Geoffrey Gates gifted 5,104 shares, decreasing direct ownership by 9% to 52,864 units (SEC Form 4)

    4 - AEHR TEST SYSTEMS (0001040470) (Issuer)

    3/10/26 8:20:55 PM ET
    $AEHR
    Electrical Products
    Industrials

    EVP, CFO and Treasurer Kelly James Patrick converted options into 12,223 shares and covered exercise/tax liability with 5,904 shares, increasing direct ownership by 5% to 130,599 units (SEC Form 4)

    4 - NOVAVAX INC (0001000694) (Issuer)

    3/9/26 6:13:36 PM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form 4 filed by EVP, CFO and Treasurer Kelly James Patrick

    4/A - NOVAVAX INC (0001000694) (Issuer)

    3/9/26 6:12:20 PM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEHR
    $AGIL
    $AIXI
    $APM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aehr Test Systems upgraded by William Blair

    William Blair upgraded Aehr Test Systems from Mkt Perform to Outperform

    3/2/26 8:27:16 AM ET
    $AEHR
    Electrical Products
    Industrials

    Mizuho initiated coverage on Pulse Biosciences with a new price target

    Mizuho initiated coverage of Pulse Biosciences with a rating of Outperform and set a new price target of $25.00

    1/30/26 6:44:12 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Hawaiian Electric downgraded by Jefferies with a new price target

    Jefferies downgraded Hawaiian Electric from Hold to Underperform and set a new price target of $12.50

    1/20/26 9:08:47 AM ET
    $HE
    Electric Utilities: Central
    Utilities

    $AEHR
    $AGIL
    $AIXI
    $APM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cornog William L bought $67,300 worth of shares (5,000 units at $13.46) (SEC Form 4)

    4 - BrightView Holdings, Inc. (0001734713) (Issuer)

    2/9/26 4:30:07 PM ET
    $BV
    Real Estate

    Director Cornog William L bought $128,400 worth of shares (10,000 units at $12.84) (SEC Form 4)

    4 - BrightView Holdings, Inc. (0001734713) (Issuer)

    12/3/25 5:00:18 PM ET
    $BV
    Real Estate

    Director Duggan Robert W bought $2,788,624 worth of shares (192,599 units at $14.48), increasing direct ownership by 0.41% to 47,709,140 units (SEC Form 4)

    4 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    9/12/25 8:14:18 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $AEHR
    $AGIL
    $AIXI
    $APM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform

    KUALA LUMPUR, Malaysia, March 11, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) today announced that, in connection with its Fidelion Diagnostics Pte. Ltd ("Fidelion") transaction, Dr. Muthu Meyyappan has been appointed Chief Commercial Officer of Fidelion. Fidelion is a precision diagnostics company focused on advancing next-generation oncology testing technologies, including minimal residual disease (MRD) liquid biopsy assays. Fidelion serves as the international intellectual property and commercialization vehicle for the VitaGuard™ MRD technology developed by Tongshu Gene, supporting commercialization initiatives outside Greater China. BGLC is a strategic investor in Fi

    3/11/26 8:45:00 AM ET
    $BGLC
    Medical Specialities
    Health Care

    Diamond Equity Research Releases Update Note on Genius Group Ltd. (NYSE: GNS)

    New York, March 11, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an update note on Genius Group Ltd. (NYSE:GNS). The update note includes information on the Genius Group Ltd.' financial results, management commentary, recent developments, outlook, and risks. The research summary below is from a report commissioned by Genius Group Ltd. and produced by Diamond Equity Research. Investors can find various risk factors in the update report and in the respective financial filings for Genius Group Limited.  The full research report is available below. Genius Group March 2026 Update Note  Highlights

    3/11/26 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

    NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, March 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ:APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, and DiamiR Biosciences Corp. ("DiamiR"), a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced the publication of a paper by Giliberto, et. al. titled "Development of microRNA-Based Glioblastoma Biomarkers Using Blood Plasma Specimens" in Diagnostics, (https://doi.org/10.3390/diagnostics16050791), a leading peer-reviewed journal focused on clinical diagnostics and biomarker research. This study, condu

    3/10/26 8:00:00 AM ET
    $APM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHR
    $AGIL
    $AIXI
    $APM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AEHR
    $AGIL
    $AIXI
    $APM
    SEC Filings

    View All

    SEC Form 6-K filed by VinFast Auto Ltd.

    6-K - VinFast Auto Ltd. (0001913510) (Filer)

    3/11/26 6:00:57 AM ET
    $VFS
    Auto Manufacturing
    Industrials

    SEC Form 6-K filed by Genius Group Limited

    6-K - Genius Group Ltd (0001847806) (Filer)

    3/9/26 4:30:13 PM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 20-F filed by Genius Group Limited

    20-F - Genius Group Ltd (0001847806) (Filer)

    3/9/26 4:16:06 PM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AEHR
    $AGIL
    $AIXI
    $APM
    Leadership Updates

    Live Leadership Updates

    View All

    BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

    Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), today announced the completion of a governance restructuring of its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd. ("Chemrex"). As part of this restructuring, Chemrex's board has been streamlined to two directors: Matthew L. Barsing, ChairmanAngeline Chong, Chief Financial Officer of BioNexus, Director New officers are expected to be appointed in the coming months. Chemrex remains a wholly owned private subsidiary of BioNexus and operates un

    2/23/26 8:30:00 AM ET
    $BGLC
    Medical Specialities
    Health Care

    Jabil Announces Appointment of New Chairman, Directors to the Board

    Jabil Inc. (NYSE:JBL), a global engineering, supply chain, and manufacturing solutions provider, today announced that Steve Raymund has been appointed Chairman of its Board of Directors. Additionally, Thomas T. Edman and Raejeanne Skillern have been appointed to its Board of Directors. "I am honored to accept this role and look forward to collaborating with the rest of the Board to continue advancing Jabil's strategic direction," said Raymund. "We are also pleased to welcome Tom and Raejeanne to our Board. Tom's leadership in electronics manufacturing paired with Raejeanne's experience in key growth industries like cloud and data centers will be terrific additions to Jabil." Mr. Raymund

    1/22/26 4:15:00 PM ET
    $JBL
    Electrical Products
    Technology

    Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. "We are delighted to welcome Maria to our Board of Directors," said Pulse Biosciences' Co-Chairman of the Board Robert W. Duggan. "She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse begins creating and disrupting interventional m

    1/9/26 7:00:00 AM ET
    $AVNS
    $HYPR
    $OFIX
    Industrial Specialties
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Medical/Dental Instruments

    $AEHR
    $AGIL
    $AIXI
    $APM
    Financials

    Live finance-specific insights

    View All

    Jabil's Second Quarter of Fiscal Year 2026 Earnings Announcement Set

    Jabil Inc. (NYSE:JBL) today announced it will release its second quarter of fiscal year 2026 financials on Wednesday, March 18, 2026, before the market opens. The company will host a conference call and webcast to review the results. What: Jabil's Second Quarter of Fiscal Year 2026 Conference Call and Webcast When: Wednesday, March 18, 2026 – 8:30 a.m. ET Dial-in: U.S. (877) 407-6184 or International (201) 389-0877 To access the live audio webcast and the accompanying slide presentation, visit the Investor Relations section of Jabil's website, located at https://investors.jabil.com. An archived replay of the webcast will be available after completion of the call. About Jabil:

    3/4/26 4:15:00 PM ET
    $JBL
    Electrical Products
    Technology

    Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

    Pfizer agreement announced in January 2026 for non-exclusive license to utilize Matrix-M® in two infectious disease areasMultiple Material Transfer Agreements signed in 2025 and Q1 2026 with pharmaceutical companies, including major global pharmaceutical companies exploring the utility of Matrix-M for their vaccine portfolios Successful execution of Sanofi partnership with $225 million in milestones earned in full year 2025Total revenue of $147 million in the fourth quarter of 2025 and $1.1 billion for the full year 2025Continued advancement of early-stage pipeline with the intention to enter the clinic as early as 2027Year end 2025 Cash of $751 million Novavax exceeded its full year 2025 R&

    2/26/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

    Full year 2025 net revenues of $655 million and fourth quarter net revenues of $174 million Optune Pax® approved by the U.S. FDA for the treatment of locally advanced pancreatic cancer, commercial launch underway Novocure (NASDAQ:NVCR) today reported financial results for the quarter and full year ended December 31, 2025. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, Tumor Treating Fields (TTFields). "In 2025, a record number of patients received treatment with Novocure's Tumor Treating Fields therapy, a milestone that reflects our growth and commitment to advanc

    2/26/26 7:00:00 AM ET
    $NVCR
    Medical/Dental Instruments
    Health Care

    $AEHR
    $AGIL
    $AIXI
    $APM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Upwork Inc.

    SC 13G/A - UPWORK, INC (0001627475) (Subject)

    12/9/24 6:02:26 AM ET
    $UPWK
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:32:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:31:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials